Lisanti Capital Growth Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$3.29M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$3.16M |
| 3 |
RYL
RYLAND GROUP INC
RYL
|
+$2.76M |
| 4 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$2.74M |
| 5 |
Qualys
QLYS
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$4.68M |
| 2 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$4.23M |
| 3 |
Monolithic Power Systems
MPWR
|
+$4.06M |
| 4 |
HEES
H&E Equipment Services
HEES
|
+$3.65M |
| 5 |
SLCA
U.S. SILICA HOLDINGS, INC.
SLCA
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.63% |
| 2 | Technology | 19.58% |
| 3 | Consumer Discretionary | 18.44% |
| 4 | Industrials | 9.82% |
| 5 | Financials | 5.5% |
Similar funds
Lisanti Capital Growth's Q4 2014 Portfolio in Review
As of Q4 2014, Lisanti Capital Growth held 130 positions worth $200M, up 0.51% from $199M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Lisanti Capital Growth withdrew a net $29.1M in Q4 2014, closing 41 positions and reducing 29 holdings. Its most notable exit was Pacira BioSciences, an estimated $4.68M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Lisanti Capital Growth opened a new position in Axon Enterprise worth $4.42M.
- Lisanti Capital Growth's largest Q4 2014 buy was Axon Enterprise: 166,777 shares worth $4.42M.
- Lisanti Capital Growth added most to Paylocity in Q4 2014, an estimated $1.16M increase.
- Lisanti Capital Growth's biggest Q4 2014 reduction was Team Health Holdings Inc, cutting an estimated $2.02M.
- Lisanti Capital Growth fully exited Pacira BioSciences in Q4 2014, selling an estimated $4.68M.
- Lisanti Capital Growth's ten largest holdings make up 21% of its $200M portfolio in Q4 2014.
- Lisanti Capital Growth opened 37 new positions and closed 41 in Q4 2014.
- Lisanti Capital Growth's portfolio value rose 0.51% quarter-over-quarter to $200M.
Based on Lisanti Capital Growth's 13F filing for Q4 2014, filed 10 Feb 2015.